Medical release archive
Here you can find the archive of all Medical releases prior to 2018
Filter by date:
Showing 30 medical releases before 2018
-
US FDA approves Symbicort (budesonide/formoterol) for the treatment of asthma in paediatric patients
-
AstraZeneca supports the publication of the 2017 GOLD strategy for improving COPD diagnosis, management and prevention
-
Early data demonstrate clinical activity of acalabrutinib in difficult-to-treat chronic lymphocytic leukaemia
-
Arthritis and Rheumatology publishes positive Phase II data on anifrolumab in lupus
-
EUCLID trial results for BRILINTA/BRILIQUE presented at the American Heart Association Scientific Sessions
-
Durvalumab shows promising preliminary early data in lung and head & neck cancers
-
Phase III combination trial of Bydureon and Forxiga shows significant benefits in patients with type-2 diabetes
-
AstraZeneca announces two new Phase IIIb trials for Forxiga in chronic kidney disease and chronic heart failure
-
AstraZeneca presents further evidence for the potential of AZD9291 in first-line and pre-treated non-small cell lung cancer
-
AstraZeneca receives approval in the EU for Qtern (saxagliptin and dapagliflozin) for treatment of type-2 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations (Oncology)
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
Rebecca Einhorn
Director Global Media Relations (Oncology)
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team